hackettg

Class 4 Medicines Defect Information: Bezalip Mono 400mg Tablets (Quadrant Pharmaceuticals Limited) Drug alert number: EL (22)A/38 Date issued: 12 September 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Bezalip Mono 400mg Tablets (Quadrant Pharmaceuticals Limited) PLPI 20774/0036 Batch Number Expiry Date Pack Size [...]

The post MHRA Class 4 Medicines Defect Information: Bezalip Mono 400mg Tablets (Quadrant Pharmaceuticals Limited) appeared first on PSNC Website.

Community pharmacy contractors are advised to dispatch their paper prescriptions for August to the NHS Business Services Authority (NHSBSA) no later than the 5th of September, to mitigate against planned strike action by the Communication Workers Union (CWU). The paper prescription bundle should be sent together with the Account Identifier Document to the relevant pricing [...]

The post Postal strike action – submit your August paper prescription bundle in time appeared first on PSNC Website.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2022. ADVANCE NOTICE Pharmacy contractors should note that from October 2022, the discount applied to the monthly total of reimbursement prices will be [...]

The post Drug Tariff Watch – September 2022 appeared first on PSNC Website.

Class 2 Medicines Recall: Dysport 500 Units Powder for Solution for Injection Drug alert number: EL(22)A/36 Date issued: 22 August 2022 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Dysport 500 Units Powder for Solution for Injection PL 34926/000 Batch Number Expiry Date Pack Size First Distributed [...]

The post Class 2 Medicines Recall: Dysport 500 Units Powder for Solution for Injection appeared first on PSNC Website.

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Mexiletine hydrochloride 50mg, 100mg and 200 mg Hard Capsules, Clinigen Healthcare Ltd, due to a potential for underdosing and/or overdosing National Patient Safety Alert Reference Number: NatPSA/2022/007/MHRA Date issued: 4th August 2022 Clinigen Healthcare Ltd is initiating a recall of three batches of Mexiletine [...]

The post National Patient Safety Alert: Class 1 Medicines Recall Notification: Mexiletine hydrochloride 50mg, 100mg & 200 mg Hard Capsules (Clinigen Healthcare Ltd) appeared first on PSNC Website.